Blueprint Medicines Corp buy melinda
Start price
14.07.20
/
50%
€78.02
Target price
31.08.20
€100.00
Performance (%)
-17.59%
End price
31.08.20
€64.30
Summary
This prediction ended on 31.08.20 with a price of €64.30. The prediction for Blueprint Medicines Corp disappointed with a performance of -17.59%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Blueprint Medicines Corp | 3.088% | 3.088% | 75.470% | -6.384% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by melinda for this prediction
In the thread Blueprint Medicines Corp diskutieren
Buy mit Kursziel 100,0
In the thread Trading Blueprint Medicines Corp
Buy beendet
Stopped prediction by melinda for Blueprint Medicines Corp
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€64.30
31.08.20
31.08.20
€66.00
04.11.21
04.11.21
55.52%
05.11.21
05.11.21
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€76.30
26.05.19
26.05.19
€79.38
06.06.19
06.06.19
4.18%
06.06.19
06.06.19
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€23.36
14.12.16
14.12.16
€27.06
05.01.17
05.01.17
16.56%
05.01.17
05.01.17